Maze Therapeutics Inc. (MAZE)
NASDAQ: MAZE
· Real-Time Price · USD
13.30
-0.20 (-1.48%)
At close: Aug 18, 2025, 3:59 PM
13.34
0.30%
After-hours: Aug 18, 2025, 05:38 PM EDT
-1.48% (1D)
| Bid | 13.34 |
| Market Cap | 583.22M |
| Revenue (ttm) | 2.5M |
| Net Income (ttm) | -80.91M |
| EPS (ttm) | -1.68 |
| PE Ratio (ttm) | -7.92 |
| Forward PE | -3.83 |
| Analyst | Buy |
| Ask | 15.5 |
| Volume | 124,586 |
| Avg. Volume (20D) | 147,874.3 |
| Open | 13.61 |
| Previous Close | 13.50 |
| Day's Range | 13.23 - 13.92 |
| 52-Week Range | 6.71 - 19.19 |
| Beta | 3.13 |
About MAZE
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol MAZE
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for MAZE stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+24.26%
Maze Therapeutics shares are trading higher after ...
Unlock content with
Pro Subscription
4 months ago
-10.08%
Maze Therapeutics shares are trading lower on possible continued weakness after the company reported a year-over-year decrease in Q4 EPS results yesterday.
6 months ago · seekingalpha.com
U.S. IPO Weekly Recap: Active January Closes Out With Several Sizable IPOsFive IPOs listed this week, all of which raised over $100 million; one direct listing and three SPACs also debuted. Four microcaps submitted initial filings this week - Vistek, Awaysis Capital, QMSK T...